Memory loss is preventable.

Of all people alive today approximately 75 million of them carry genetic markers that place them at an increased risk for developing cognitive impairment. By the year 2050 it is estimated that 160 million people will develop Alzheimer's disease.

Clinical trials performed to investigate possible treatment options using a single pharmaceutical intervention have either failed or revealed only a minimally positive effect. Much of the failure of these treatments can be attributed to the lack of understanding of the development of this disease itself. 

Chronic illnesses are complex and new research is revealing that they can not be adequately addressed using the single pill-for-an-ill model. Alzheimer’s disease is not a single disease with a single etiology (as previously suggested) but rather several different diseases with multiple etiologies.

The development of Alzheimer’s disease is a survival response. When our bodies are starved for basic building blocks, the neurologic system begins to downsize in an effort to maintain its most vital processes. By understanding and identifying your risk factors for developing cognitive impairment, we can together correct underlying imbalances and eliminate triggers, leading to the prevention and even reversal of memory loss. 

 
 
 

Programs

Our program consistent of two main branches.

 
 

PREVENTION

 
 

The Prevention Program is ideal for anyone with a history of cognitive impairment in their family. It is also good for anyone wanting to stratify their risk for disease and gain insight into how to reduce their risk for the development of memory loss. This program helps optimize your general health status.

REVERSAL

 
 

The Reversal Program is ideal for anyone currently experiencing memory loss. Due to the accelerated nature of this program, this customized treatment protocol will require a great deal of dedication and personal commitment in order to achieve optimal results.

 

Supporting Research

The Bredesen Protocol was developed by Dale Bredesen, MD, an internationally recognized expert in the mechanisms of neurodegenerative diseases such as Alzheimer’s disease. He graduated from Caltech, then earned his MD from Duke University Medical Center in Durham, North Carolina. He was the Founding President and CEO of the Buck Institute for Research on Aging and the Director of the Easton Center for Alzheimer’s Disease Research at UCLA. His book, The End of Alzheimer's, is a New York Times Bestseller.

 
 

The End of Alzheimer’s by Dale Bredesen, MD

Articles by Dale Bredesen, MD

About Dale Bredesen, MD

 

 
 

Practitioners

Our practitioners have been trained through The Buck Institute for Research on Aging and have completed formal training in the Bredesen Protocol developed by Dr. Dale Bredesen, one of the world’s leading researchers in Alzheimer's disease.

What to expect

Our practitioners are committed to providing you with the very best care. During your first appointment you will meet with one of our physicians and undergo a comprehensive health assessment.

Our practitioner will determine what specialized testing is needed. Testing may include MRI or PET imaging of the brain, neurocognitive testing, as well as laboratory analysis.

We work together to develop a detailed and customized plan. Follow-ups are often scheduled monthly and results are typically seen within three to six months of consistent treatment.

 

Connect with a practitioner

Please fill out the form to begin the process. A practitioner will contact you within 48 hours.